Clinical Outcomes in Pediatric Obsessive-Compulsive Disorder
Recruiting now NCT01635569
Run by University of British Columbia · for 5 to 18 · All sexes
What this study is about
Obsessive-Compulsive Disorder (OCD) is a common neuropsychiatric illness beginning in childhood. Effective OCD treatments include cognitive-behaviour therapy (CBT) and medications but access to treatment is difficult and does not systematically include parents. The investigators will evaluate clinical and neural effects of Group-based Family CBT (GF-CBT), via a case-control study including: Group 1 - OCD cases receiving GF-CBT (N=90); Group 2 - OCD waitlist cases (N=90). Effects will be measured between baseline and completion of 12 GF-CBT sessions: comparing OCD severity and functioning changes between Groups 1 and 2.
Who can join (things the study team will check)
✅ You may be able to join if…
- Male or female, aged 5-18 years old
- Ability of subject and parent to provide informed assent/consent
- English-speaking
- Current DSM IV-TR Axis I diagnosis of childhood-onset OCD; Moderate to severe OCD (CY-BOCS≥16/40)
🚫 You may not be able to join if…
- Current diagnosis of bipolar disorder, psychosis, mental retardation or pervasive developmental disorder (e.g., autism), and current or past substance dependence/abuse
Where this trial is running
- BC Children's Hospital Research Institute, Vancouver, British Columbia, Canada
Who to contact
Diana Franco Yamin, MA · dfrancoy@bcchr.ca
It's completely normal to call and ask questions before deciding anything. Mention the study ID: NCT01635569.
Verify everything on the official ClinicalTrials.gov record. Page updated July 2026.